ATA291279A - Verfahren zur herstellung von neuen 4-desacetyl vincaleucoblastin-c3-carbonsaeurehydraziden - Google Patents

Verfahren zur herstellung von neuen 4-desacetyl vincaleucoblastin-c3-carbonsaeurehydraziden

Info

Publication number
ATA291279A
ATA291279A AT792912A AT291279A ATA291279A AT A291279 A ATA291279 A AT A291279A AT 792912 A AT792912 A AT 792912A AT 291279 A AT291279 A AT 291279A AT A291279 A ATA291279 A AT A291279A
Authority
AT
Austria
Prior art keywords
vincaleucoblastin
desacetyl
carbonic acid
producing new
acid hydrazides
Prior art date
Application number
AT792912A
Other languages
English (en)
Other versions
AT369010B (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to AT533781A priority Critical patent/AT377764B/de
Priority to AT533881A priority patent/AT377765B/de
Publication of ATA291279A publication Critical patent/ATA291279A/de
Application granted granted Critical
Publication of AT369010B publication Critical patent/AT369010B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT0291279A 1978-04-20 1979-04-18 Verfahren zur herstellung von neuen 4-desacetyl -vincaleucoblastin-c3-carbonsaeurehydraziden AT369010B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT533781A AT377764B (de) 1978-04-20 1981-12-14 Verfahren zur herstellung von neuen 4-desacetyl-vincaleucoblastin-c3carbons|urehydraziden
AT533881A AT377765B (de) 1978-04-20 1981-12-14 Verfahren zur herstellung von neuen 4-desacetyl-vincaleucoblastin-c3carbons|urehydraziden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/899,032 US4166810A (en) 1978-04-20 1978-04-20 Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide

Publications (2)

Publication Number Publication Date
ATA291279A true ATA291279A (de) 1982-04-15
AT369010B AT369010B (de) 1982-11-25

Family

ID=25410402

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0291279A AT369010B (de) 1978-04-20 1979-04-18 Verfahren zur herstellung von neuen 4-desacetyl -vincaleucoblastin-c3-carbonsaeurehydraziden

Country Status (32)

Country Link
US (1) US4166810A (de)
EP (1) EP0005051B1 (de)
JP (1) JPS54141798A (de)
AR (1) AR228940A1 (de)
AT (1) AT369010B (de)
AU (1) AU527109B2 (de)
BE (1) BE875652A (de)
BG (3) BG33297A3 (de)
CA (1) CA1097629A (de)
CH (1) CH643269A5 (de)
CS (3) CS218584B2 (de)
DD (1) DD143075A5 (de)
DE (1) DE2964130D1 (de)
DK (1) DK147484C (de)
EG (1) EG14867A (de)
ES (2) ES479754A1 (de)
FI (1) FI791286A7 (de)
FR (1) FR2423495A1 (de)
GB (1) GB2019396B (de)
GR (1) GR69987B (de)
HU (1) HU181431B (de)
IE (1) IE48213B1 (de)
IL (1) IL57168A (de)
LU (1) LU81166A1 (de)
NZ (1) NZ190213A (de)
PH (1) PH14163A (de)
PL (3) PL125470B1 (de)
PT (1) PT69496A (de)
RO (3) RO81037A (de)
SU (3) SU893135A3 (de)
YU (1) YU93179A (de)
ZA (1) ZA791856B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322351A (en) * 1980-08-25 1982-03-30 Eli Lilly And Company Antineoplastic 4'-formylamino and 4'-acetylamino VLB, and derivatives thereof
ATE57187T1 (de) * 1983-03-30 1990-10-15 Lilly Industries Ltd Vincaleukoblastin-derivate.
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
US5043336A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Cyclic imide derivatives of 4-desacetyl VLB c-3 carboxhydrazide
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide
EP1389209B1 (de) * 2001-04-24 2009-04-08 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
ES2324708T3 (es) * 2002-05-15 2009-08-13 Endocyte, Inc. Conjugados de vitamina-mitomicina.
EP1592457B1 (de) 2003-01-27 2012-07-25 Endocyte, Inc. Folat-vinblastin konjugat als arzneimittel
US8288557B2 (en) * 2004-07-23 2012-10-16 Endocyte, Inc. Bivalent linkers and conjugates thereof
CN101175757B (zh) * 2005-03-16 2012-11-14 恩多塞特公司 蝶酸及其缀合物的合成和纯化
CN103893779A (zh) 2005-08-19 2014-07-02 恩多塞特公司 多药物配体缀合物
EP1948240A2 (de) * 2005-08-19 2008-07-30 Endocyte, Inc. Liganden-konjugate von vinca-alkaloiden, analoga und derivaten
US20100087370A1 (en) * 2007-02-14 2010-04-08 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
US20100104626A1 (en) * 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
CN101678124A (zh) * 2007-03-14 2010-03-24 恩多塞特公司 结合配体连接的微管溶素递药缀合物
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
CN104383553A (zh) 2007-06-25 2015-03-04 恩多塞特公司 含有亲水性间隔区接头的共轭物
AU2008316835B2 (en) * 2007-10-25 2015-07-16 Endocyte, Inc. Tubulysins and processes for preparing
JP5780961B2 (ja) * 2009-09-07 2015-09-16 ニプロパッチ株式会社 経皮吸収型製剤
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
US9662402B2 (en) 2012-10-16 2017-05-30 Endocyte, Inc. Drug delivery conjugates containing unnatural amino acids and methods for using

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3205220A (en) * 1961-10-26 1965-09-07 Lilly Co Eli Leurosidine and leurocristine and their production
US3392173A (en) * 1964-03-09 1968-07-09 Lilly Co Eli Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation
US3370057A (en) * 1964-04-27 1968-02-20 Lilly Co Eli Leurosine
US3387001A (en) * 1964-10-19 1968-06-04 Lilly Co Eli Novel aminoacyl esters of desacetyl vincaleukoblastine
US3887565A (en) * 1974-05-06 1975-06-03 Lilly Co Eli Vincadioline
US3890325A (en) * 1974-05-15 1975-06-17 Lilly Co Eli Leurocolombine
US3954773A (en) * 1974-11-21 1976-05-04 Eli Lilly And Company 4-Desacetoxyvinblastine
US3944554A (en) * 1975-01-09 1976-03-16 Eli Lilly And Company 4-Desacetoxy-3-hydroxyvinblastine
IL48685A (en) 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
US4115388A (en) * 1977-03-30 1978-09-19 Eli Lilly And Company 3'-Oxygenated derivatives of 4'-deoxy VLB "A" and "B" and related 1-formyl compounds

Also Published As

Publication number Publication date
SU1061698A3 (ru) 1983-12-15
GB2019396B (en) 1982-09-15
AT369010B (de) 1982-11-25
AU527109B2 (en) 1983-02-17
AU4609779A (en) 1979-10-25
JPS54141798A (en) 1979-11-05
PH14163A (en) 1981-03-19
RO81037A (ro) 1983-02-01
RO81114A (ro) 1983-02-01
EG14867A (en) 1986-09-30
YU93179A (en) 1983-01-21
BG33297A3 (bg) 1983-01-14
GR69987B (de) 1982-07-22
FR2423495B1 (de) 1983-02-11
BG33294A3 (bg) 1983-01-14
DD143075A5 (de) 1980-07-30
CH643269A5 (fr) 1984-05-30
RO80084A (ro) 1983-02-01
SU1225490A3 (ru) 1986-04-15
DK147484C (da) 1985-03-25
GB2019396A (en) 1979-10-31
IE790795L (en) 1979-10-20
RO80084B (ro) 1983-01-30
CA1097629A (en) 1981-03-17
PL215911A1 (de) 1980-03-24
FR2423495A1 (fr) 1979-11-16
DK160679A (da) 1979-10-21
ES479754A1 (es) 1980-08-16
BG33296A3 (bg) 1983-01-14
HU181431B (en) 1983-07-28
FI791286A7 (fi) 1981-01-01
PL119416B1 (en) 1981-12-31
EP0005051B1 (de) 1982-12-01
BE875652A (fr) 1979-10-18
PL125470B1 (en) 1983-05-31
IL57168A0 (en) 1979-07-25
SU893135A3 (ru) 1981-12-23
AR228940A1 (es) 1983-05-13
JPS6245873B2 (de) 1987-09-29
IE48213B1 (en) 1984-10-31
RO81114B (ro) 1983-01-30
CS218584B2 (en) 1983-02-25
DE2964130D1 (en) 1983-01-05
IL57168A (en) 1983-10-31
CS218585B2 (en) 1983-02-25
RO81037B (ro) 1983-01-30
NZ190213A (en) 1982-12-21
CS218583B2 (en) 1983-02-25
US4166810A (en) 1979-09-04
PT69496A (en) 1979-05-01
ZA791856B (en) 1980-11-26
EP0005051A1 (de) 1979-10-31
ES479753A1 (es) 1980-08-16
DK147484B (da) 1984-08-27
LU81166A1 (fr) 1979-09-07

Similar Documents

Publication Publication Date Title
AT368168B (de) Verfahren zur herstellung von neuen thioetiansaeurederivaten
AT366689B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
AT369010B (de) Verfahren zur herstellung von neuen 4-desacetyl -vincaleucoblastin-c3-carbonsaeurehydraziden
ATA590580A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT376684B (de) Verfahren zur herstellung von neuen bor-silicium- verbindungen
AT366365B (de) Verfahren zur herstellung von neuen 4-nitro-2trichlormethylphenyldisulfiden
AT362872B (de) Verfahren zur herstellung von neuen demethylmaytansinoiden
AT367397B (de) Verfahren zur herstellung von neuen n-phenaethyl- glycinamiden
AT369377B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT365564B (de) Verfahren zur herstellung von neuen alpha-phenylbenzylidenaminoalkansaeurederivaten
AT367052B (de) Verfahren zur herstellung von neuen modifizierten azulminsaeuren
AT364347B (de) Verfahren zur herstellung von neuen 1beta-hydroxy-2beta-alkenyl-3-methylencyclopentan-4 beta-yl-cyclopropancarboxylaten
ATA291979A (de) Verfahren zur herstellung von neuen ver- bindungen
AT368516B (de) Verfahren zur herstellung von neuen nitrosoharnstoff-verbindungen
AT362067B (de) Verfahren zur herstellung von neuen deoxyanthracyclinen
AT368517B (de) Verfahren zur herstellung von neuen nitrosoharnstoffverbindungen
AT368155B (de) Verfahren zur herstellung von neuen vincamonsalzen
AT366698B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT371475B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA246881A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA491581A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA491481A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA330681A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA831278A (de) Verfahren zur herstellung von neuen 3-di-n- -propyl-acetoxy-benzodiazepin-2-onen
AT369368B (de) Verfahren zur herstellung von neuen modifizierten azulminsaeuren

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee